Global Aneurysm Coiling and Embolization Devices Market 2022-2026

Global Aneurysm Coiling and Embolization Devices Market 2022-2026

Technavio has been monitoring the aneurysm coiling and embolization devices market and it is poised to grow by $ 1.87 bn during 2022-2026 progressing at a CAGR of 9.06% during the forecast period. Our report on the aneurysm coiling and embolization devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of IAs and associated risk factors, increasing frequency of UIAs detection, and technological advances in aneurysm coiling and embolization devices.

The aneurysm coiling and embolization devices market analysis includes the product segment and geographic landscape.

Technavio's aneurysm coiling and embolization devices market is segmented as below:

By Product

• Embolization coils
• Access and delivery services
• Aneurysm clips
• Balloon and stent assisted coils
• Flow diversion devices

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing demand for flow diversion as an alternative to neurovascular coiling as one of the prime reasons driving the aneurysm coiling and embolization devices market growth during the next few years. Also, increasing focus on new product launches and increasing initiatives to increase awareness of IAs will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on aneurysm coiling and embolization devices market covers the following areas:

• Aneurysm coiling and embolization devices market sizing
• Aneurysm coiling and embolization devices market forecast
• Aneurysm coiling and embolization devices market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading aneurysm coiling and embolization devices market vendors that include Acandis GmbH, Asahi Intecc Co. Ltd., B Braun Melsungen AG, BALT Group, Braile Biomedica, Cook Group Inc., Integer Holdings Corp., Johnson and Johnson, Kaneka Corp., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corp., Penumbra Inc., phenox GmbH, Stryker Corp., Terumo Corp., and Medtronic Plc. Also, the aneurysm coiling and embolization devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Companies Mentioned

Acandis GmbH, Asahi Intecc Co. Ltd., B Braun Melsungen AG, BALT Group, Braile Biomedica, Cook Group Inc., Integer Holdings Corp., Johnson and Johnson, Kaneka Corp., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corp., Penumbra Inc., phenox GmbH, Stryker Corp., Terumo Corp., Medtronic Plc